West Vancouver BC- Imagine if there was a significant increase in accurately diagnosing and treating disease for all British Columbians. The benefits of using genetic information to create a personalized approach to health care are vast. Genome British Columbia (Genome BC) is taking its community engagement program, “Bringing Genomics Home” to West Vancouver for an informative talk on the role of genomics in medical diagnosis and treatment.
Community members are welcome to join Drs. Brad Popovich, Joseph Connors, Stuart Turvey and Mel Krajden for an engaging and lively presentation: Your DNA: a blueprint for better health. The talk will dive into the opportunities, applications and potential impacts of personalized medicine over the next five years.
Topics and speakers are:
Personalized Medicine: what's the prescription for BC in the next 5 years?
Brad Popovich PhD, Genome BC
Cancer: unlocking a genetically driven disease
Joseph M Connors MD FRCPC, BC Cancer Agency Centre
Mystery Patients: Using genomic tools to help diagnose and treat rare disease
Stuart Turvey MBBS, BC Children’s Hospital
Hepatitis C: 25 years from discovery to cure
Mel Krajden MD, BC Centre for Disease Control
“Genomics is going to transform healthcare over the next twenty years, particularly how we monitor and treat disease”, says Dr. Alan Winter, President and CEO of Genome BC. “This exciting area of medicine is still in early stages but we are delighted to be bringing these experts together in West Vancouver to share their significant insight and knowledge on the opportunity for genomics and personalized medicine.”
This free public talk begins at 7:00pm on Wednesday, November 18th at the Kay Meek Centre 1700 Mathers avenue. For more information and to register for this free event please visit: www.genomebc.ca/bghwestvancouver
Dr. Brad Popovich, PhD
Dr. Popovich is the former Chief Scientific Officer for Genome BC. Brad has been a pioneer in the application of DNA technologies for the diagnosis and management of human diseases. He co-authored the first genetic privacy law in the US, was the prosecutions DNA expert in the OJ Simpson trial, and has been involved in a myriad of ancillary issues in the field of clinical molecular genetics. He is presently the Chairman of Microbiome Insights, and Genetic Information Management Systems, and a Director of the Centre for Drug Research and Development.
Dr. Joseph Connors, MD FRCPC
Joseph M. Connors is a clinical professor in the Department of Medicine, Division of Medical Oncology, at the University of British Columbia and the Clinical Director of the BC Cancer Agency Centre for Lymphoid Cancer. Dr. Connors is best known for his clinical investigations into the treatment of Hodgkin lymphoma, non-Hodgkin lymphoma, chronic lymphocytic leukemias and multiple myeloma.
Dr. Stuart Turvey, MBBS DPhil FRCPC
Stuart Turvey is a Professor of Pediatrics at the University of British Columbia where he holds the Aubrey J. Tingle Professorship in Pediatric Immunology. He is a Pediatric Immunologist based at BC Children’s Hospital, and Director of Clinical Research at the Child & Family Research Institute.
Dr Turvey provides clinical care in the specialties of Clinical Immunology and Rheumatology, while his research program focuses on pediatric infectious and inflammatory diseases.
Dr. Mel Krajden, MD FRCPC
Mel Krajden is the Medical Head of Hepatitis - Clinical Prevention Services and the Associate Medical Director of the Public Health Microbiology and Reference Laboratory and Head of Virology at the British Columbia Centre for Disease Control. He is also a Professor of Pathology and Laboratory Medicine at the University of British Columbia.
About Genome British Columbia:
Genome British Columbia is a catalyst for the life sciences cluster on Canada’s West Coast and manages a cumulative portfolio of over $710M in research projects and science and technology platforms. Working with governments, academia and industry across sectors such as forestry, fisheries, agriculture, environment, bioenergy, mining and human health, the goal of the organization is to generate social and economic benefits for British Columbia and Canada.
In addition to research, Genome BC is committed to public outreach and educational leadership, and as such, seeks to foster understanding and appreciation of the significance of genomics science and technology among teachers, students and the general public. www.genomebc.ca
For more information contact: